Tag: Aravax

Research

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Reasearcher

Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy

What they discover could guide the design of a new strategy for immune intervention.
Researchers

Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials

Vaccine uses peptides selected from parts of the peanut protein that do not cause life-threatening anaphylactic reactions.